Related Experiment Video
Updated: Aug 25, 2025

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling
Published on: October 28, 2014
Dysfunctional tRNA reprogramming and codon-biased translation in cancer
Peter C Dedon1, Thomas J Begley2
1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Singapore-MIT Alliance for Research and Technology, Antimicrobial Resistance IRG, Campus for Research Excellence and Technological Enterprise, Singapore 138602, Singapore.
Abstract:
Many cancers hijack translation to increase the synthesis of tumor-driving proteins, the messenger mRNAs of which have specific codon usage patterns. Termed 'codon-biased translation' and originally identified in stress response regulation, this mechanism is supported by diverse studies demonstrating how the 50 RNA modifications of the epitranscriptome, specific tRNAs, and codon-biased mRNAs are used by oncogenic programs to promote proliferation and chemoresistance. The epitranscriptome writers METTL1-WDR4, Elongator complex protein (ELP)1-6, CTU1-2, and ALKBH8-TRM112 illustrate the principal mechanism of codon-biased translation, with gene amplifications, increased RNA modifications, and enhanced tRNA stability promoting cancer proliferation. Furthermore, systems-level analyses of 34 tRNA writers and 493 tRNA genes highlight the theme of tRNA epitranscriptome dysregulation in many cancers and identify candidate tRNA writers, tRNA modifications, and tRNA molecules as drivers of pathological codon-biased translation.
Insights
Cancer cells exploit codon-biased translation, altering messenger RNA patterns to boost tumor protein production. This mechanism, involving epitranscriptome modifications and specific tRNAs, promotes cancer growth and resistance to therapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Cancers utilize altered translation to synthesize proteins that drive tumor growth.
- Messenger RNAs (mRNAs) in tumors exhibit specific codon usage patterns, a phenomenon termed codon-biased translation.
- This mechanism is linked to the epitranscriptome, transfer RNAs (tRNAs), and oncogenic programs promoting proliferation and chemoresistance.
Purpose of the Study:
- To elucidate the role of codon-biased translation in cancer.
- To investigate the contribution of epitranscriptome modifications and tRNAs in promoting cancer progression.
- To identify key molecular players in pathological codon-biased translation.
Main Methods:
- Analysis of epitranscriptome writers (e.g., METTL1-WDR4, Elongator complex proteins, CTU1-2, ALKBH8-TRM112).
- Examination of gene amplifications, RNA modifications, and tRNA stability.
- Systems-level analysis of tRNA writers and tRNA genes.
Main Results:
- Epitranscriptome writers facilitate codon-biased translation, with associated gene amplifications, increased RNA modifications, and enhanced tRNA stability promoting cancer proliferation.
- Dysregulation of the tRNA epitranscriptome is a common theme in many cancers.
- Specific tRNA writers, tRNA modifications, and tRNA molecules are identified as drivers of pathological codon-biased translation.
Conclusions:
- Codon-biased translation is a critical mechanism hijacked by cancers to promote proliferation and chemoresistance.
- The epitranscriptome and tRNA machinery are key regulators of this process in oncogenesis.
- Targeting components of the tRNA epitranscriptome offers potential therapeutic strategies for cancer treatment.
Related Concept Videos
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Leaky Scanning
Improving Translational Accuracy
RNA Splicing
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Nucleolus

